Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (331-340 of 1,112) with videos related to

Pageof 112
Sort By:
International Journal of Stroke : Official Journal of the International Stroke Society|September 15, 2012
Demographics, socio-economic characteristics, and risk factor prevalence in patients with non-cardioembolic ischaemic stroke in low- and middle-income countries: the OPTIC registryHalim Abboud, Julien Labreuche, Antonio Arauz, et al.
European Heart Journal|February 16, 2008
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trialGilles Montalescot, Marc Cohen, Genevieve Salette, et al.
JAMA Internal Medicine|October 16, 2013
An education program for risk factor management after an acute coronary syndrome: a randomized clinical trialAriel Cohen, Patrick Assyag, Louise Boyer-Chatenet, et al.
Journal of the American College of Cardiology|August 28, 2007
Resting heart rate in cardiovascular diseaseKim Fox, Jeffrey S Borer, A John Camm, et al.
European Journal of Heart Failure|April 17, 2024
Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trialRahul Aggarwal, Deepak L Bhatt, Michael Szarek, et al.
American Journal of Preventive Cardiology|January 30, 2026
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKMMichael Miller, Deepak L Bhatt, Eliot A Brinton, et al.
European Journal of Preventive Cardiology|October 25, 2021
Impact of smoking on cardiovascular outcomes in patients with stable coronary artery diseaseNadia Bouabdallaoui, Nathan Messas, Nicola Greenlaw, et al.
Circulation|September 13, 2017
Timing of Angiography and Outcomes in High-Risk Patients With Non-ST-Segment-Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban)Pierre Deharo, Gregory Ducrocq, Christoph Bode, et al.
European Heart Journal|September 2, 2009
Unprotected left main revascularization in patients with acute coronary syndromesGilles Montalescot, David Brieger, Kim A Eagle, et al.
Journal of the Neurological Sciences|October 10, 2009
Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH RegistryShinichiro Uchiyama, Shinya Goto, Masayasu Matsumoto, et al.
Pageof 112

Showing results (331-340 of 1,112) with videos related to

Sort By:
Pageof 112
International Journal of Stroke : Official Journal of the International Stroke Society|September 15, 2012
Demographics, socio-economic characteristics, and risk factor prevalence in patients with non-cardioembolic ischaemic stroke in low- and middle-income countries: the OPTIC registryHalim Abboud, Julien Labreuche, Antonio Arauz, et al.
European Heart Journal|February 16, 2008
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trialGilles Montalescot, Marc Cohen, Genevieve Salette, et al.
JAMA Internal Medicine|October 16, 2013
An education program for risk factor management after an acute coronary syndrome: a randomized clinical trialAriel Cohen, Patrick Assyag, Louise Boyer-Chatenet, et al.
Journal of the American College of Cardiology|August 28, 2007
Resting heart rate in cardiovascular diseaseKim Fox, Jeffrey S Borer, A John Camm, et al.
European Journal of Heart Failure|April 17, 2024
Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trialRahul Aggarwal, Deepak L Bhatt, Michael Szarek, et al.
American Journal of Preventive Cardiology|January 30, 2026
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKMMichael Miller, Deepak L Bhatt, Eliot A Brinton, et al.
European Journal of Preventive Cardiology|October 25, 2021
Impact of smoking on cardiovascular outcomes in patients with stable coronary artery diseaseNadia Bouabdallaoui, Nathan Messas, Nicola Greenlaw, et al.
Circulation|September 13, 2017
Timing of Angiography and Outcomes in High-Risk Patients With Non-ST-Segment-Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban)Pierre Deharo, Gregory Ducrocq, Christoph Bode, et al.
European Heart Journal|September 2, 2009
Unprotected left main revascularization in patients with acute coronary syndromesGilles Montalescot, David Brieger, Kim A Eagle, et al.
Journal of the Neurological Sciences|October 10, 2009
Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH RegistryShinichiro Uchiyama, Shinya Goto, Masayasu Matsumoto, et al.
Pageof 112